Dunnia sinensis

Other Names

Dunnia sinensis Tutcherjiǎ huáng yángxiù qiú qiànxiu qiu qian caoxiù qiú qiàn shǔyě biǎn dòu假黄杨绣球茜绣球茜属绣球茜草野扁豆

Synopsis

Dunnia sinensis: A Comprehensive Reference

1. Identity and Botanical Description

Dunnia sinensis Tutcher belongs to a monotypic genus of flowering plants in the family Rubiaceae, subfamily Rubioideae, and tribe Hedyotideae. It comprises a single species, Dunnia sinensis Tutcher, which is endemic to southeastern China. In Chinese botanical literature, the plant is recorded under several vernacular names: 绣球茜 (xiù qiú qiàn), 假黄杨 (jiǎ huáng yáng), and 绣球茜草 (xiù qiú qiàn cǎo), as listed in the Flora Reipublicae Popularis Sinicae and the List of Plant Species in China (2022 Edition).

The species was formally described by William J. Tutcher, then director of the Hong Kong Botanical Garden, in 1905 as the monotypic genus Dunnia with the species D. sinensis. The genus is named after Stephen Troyte Dunn (1868–1938), a British botanist who served as superintendent of the Hong Kong Botanical and Afforestation Department from 1901 to 1915 and organized extensive plant collections in southern China. Dunn facilitated the gathering of the type specimen in 1904 by one of his native collectors near Sanning (now Xinning), Guangdong Province.

Dunnia sinensis Tutch. is endemic to the south of Guangdong Province in China. It is a woody shrub with a height of up to 3 m, flowering from late April to May and fruiting in October and November. This rare shrub features opposite leaves without domatia, persistent triangular stipules, and terminal corymbose-cymose inflorescences with elongated peduncles and petaloid bracts that mimic calycophylls. The flowers are bisexual and distylous, with yellow salverform or funnelform corollas that are villous inside, four- or five-lobed, and produce capsular fruits that dehisce septicidally into valves containing small, winged seeds.

The plant is known in Chinese as xiù qiú qiàn cǎo (绣球茜草). It is a shrub 0.3–2.5 m tall with rather stout, subterete to angled, puberulent to pilosulous branches. The leaf blades are drying papery to leathery, narrowly lanceolate, narrowly elliptic, or oblanceolate, 7–23 × 1–6 cm, both surfaces puberulent to strigillose, with pubescence denser on principal veins.

The species' full accepted taxonomic designation is Dunnia sinensis Tutcher, and it appears in the Royal Botanic Gardens, Kew's Plants of the World Online (POWO) and the Global Biodiversity Information Facility (GBIF) databases under the family Rubiaceae. Molecular analyses have revealed that D. sinensis is closely related to Galium mollugo and Leptodermis scabrida, with strong bootstrap support, placing it firmly within the subfamily Rubioideae.

2. Geographic Distribution and Conservation Status

D. sinensis grows in subtropical evergreen broad-leaved forests at elevations of 100–600 meters, often on slopes or near streams. Its populations have declined due to habitat destruction from human activities such as urbanization and agriculture. The species is endemic to southeastern China, primarily within Guangdong Province.

It is seriously threatened due to human exploitation of its natural habitats along streams and hillsides at low altitudes. Only five isolated populations remain. Dunnia sinensis is an endangered species due to habitat destruction over the past decades. As of 2020, it remains an endangered species listed as a national key protected wild plant in China, with ongoing threats from habitat destruction.

It is a rare plant in China, with only a few small populations remaining, exhibiting low genetic diversity that heightens its vulnerability to extinction. Researchers have reported the complete chloroplast genome of this endangered endemic species (GenBank Accession Number: MN883829) to provide useful genomic information for evolutionary dynamics and conservation evaluation.

3. Traditional and Historical Use

Besides its great ornamental value, Dunnia sinensis was used as an anti-inflammatory drug in folk medicine (Wei et al. 2000). The folk medicinal use of this plant is attributed to communities in southern Guangdong Province, China — the only region where the plant naturally occurs. The reference to folk medicinal practice appears in the primary phytochemical study of the species (Wei et al., 2000, Phytochemistry 53(8):837–840) and is corroborated by its listing as a medicinal plant in scientific databases of useful plants of China.

Wikidata records Dunnia sinensis as a medicinal plant, citing A Scientific Dataset of Useful Plants of China. The species' anti-inflammatory application represents the totality of documented traditional use; it does not appear in major classical Chinese pharmacopoeias such as the Bencao Gangmu (Compendium of Materia Medica), likely reflecting both its extreme rarity and its restriction to a narrow geographic range in southern Guangdong. No documented preparation methods, dosage forms, or duration of traditional use have been described in the peer-reviewed literature beyond the characterization of its general anti-inflammatory folk application.

The plant's scarcity — with only five known wild populations — means that widespread traditional use across broad populations or time periods is not historically documented. The available scientific literature frames its folk medicinal status as a local practice in communities of the Guangdong region, without broader integration into formal Traditional Chinese Medicine (TCM) systems or inclusion in classical materia medica.

4. Key Constituents and Active Compounds

4.1 Iridoids: Dunnisinoside and Dunnisinin

The only published phytochemical investigation of Dunnia sinensis was conducted by Wei et al. (2000), published in the journal Phytochemistry. A plumieride-type iridoid glucoside, dunnisinoside, and a non-glucosidic iridoid, dunnisinin, were isolated from the leaves of Dunnia sinensis. Their structures were established by 1D and 2D NMR and FABMS experiments.

Dunnia, a monotypic genus, had not previously been chemically studied prior to this 2000 investigation, which described the isolation and structure elucidation of two new iridoids obtained from the leaves of the plant. For isolation, the ethanol percolate of powdered dry leaves was fractionated with petroleum, CHCl₃ and n-BuOH. The n-BuOH-soluble fraction was subjected to chromatography on a silica gel column, followed by recrystallization. A major iridoid, trivially named dunnisinoside (1), was isolated.

Chemically, D. sinensis is notable for producing iridoid glucosides, including the plumieride-type compound dunnisinoside and the aglycone dunnisinin, isolated from its leaves, which may contribute to its ecological role or potential medicinal properties, though further research is limited by its rarity.

4.2 Structural Class: Plumieride-Type Iridoids

Dunnisinoside belongs structurally to the plumieride-type iridoid glucosides — a subclass of cyclopentane-fused monoterpenoids that are widely distributed across the Rubiaceae family and related plant families. The iridoid class of phytochemicals includes important phytochemicals found in many traditional medicinal plants. Plumieride-type iridoids have been identified in a range of genera including Plumeria species, Allamanda, Himatanthus, and Dunnia sinensis (Wei et al., 2000).

Iridoid glycosides more broadly exhibit a spectrum of bioactivities including anti-inflammatory actions mediated by suppression of pro-inflammatory cytokines, antioxidant capacity through free-radical scavenging, neuroprotective effects, hepatoprotective and cardioprotective benefits, and anticancer potential. Their water solubility and glycosidic linkages facilitate absorption and targeted delivery, making iridoids attractive leads for drug development. However, these properties are established for the iridoid class generally — not specifically for the novel compounds dunnisinoside or dunnisinin from D. sinensis, for which no independent pharmacological studies have been published.

5. Mechanisms of Action: Relevant Iridoid Class Data

Important caveat: No mechanism-of-action studies have been published specifically for dunnisinoside or dunnisinin. The following section describes mechanisms reported for closely related plumieride-type iridoids and for iridoid glucosides as a chemical class, as the structural relatedness provides scientific context. Attributing these mechanisms directly to Dunnia sinensis compounds would require independent experimental verification.

5.1 Anti-Inflammatory Pathways

Iridoid glycosides, a class of monoterpenoid compounds known for their anti-inflammatory properties, have been found to modulate critical signaling pathways, including NF-κB, NLRP3 inflammasome, MAPK, and JAK-STAT, thereby suppressing key inflammatory cytokines such as TNF-α, IL-1β, and IL-6, while also activating antioxidant defenses.

According to molecular docking studies with plumieride-type compounds, 13-O-coumaroyl plumieride was found to exhibit superior binding affinity for both iNOS and prostaglandin E synthase-1 target receptors, suggesting potential for targeting and modulating the activity of both enzymes.

Many iridoid glycosides have been recognized as potent modulators of the NF-κB signaling pathway, producing anti-inflammatory, antioxidant, and cytoprotective effects, mostly by hindering the process of NF-κB nuclear translocation.

5.2 Plumieride-Type Compounds: Experimental Evidence

For the plumieride-type iridoids specifically — the structural class to which dunnisinoside belongs — reported bioactivities include neuropharmacological, anti-inflammatory, antioxidant, immunostimulatory, anticancer, anti-malarial, anti-dermatophytic, antimicrobial, anti-fungal, anti-viral, cytotoxic potential, and insecticidal activities, as well as effects on spermatogenesis and enzyme modulation. These activities derive from studies of plumieride isolated from other plant sources (primarily Plumeria species), not from D. sinensis isolates.

In a 2024 preclinical mouse study, CA-infected mice showed extensive dermatitis, confirmed by strong iNOS, TNF-α, IL-1β, and NF-κB genes or immune expressions. Treatment of CA-infected mice with plumieride significantly reduced the microscopic skin lesions and modulated the expression of all measured proinflammatory cytokines and inflammatory markers in a dose-dependent manner. Plumieride interfered with the expression of C. albicans virulence factors and modulated the inflammatory response in the skin of mice infected with CA.

6. Scientific Evidence by Area of Use

6.1 Anti-Inflammatory Activity

Traditional basis: Dunnia sinensis Tutch. (Rubiaceae), a rare plant endemic to the southern Guangdong Province of China, is used in folk medicine as an anti-inflammatory drug.

Scientific evidence: No clinical trials, human studies, or controlled preclinical studies have been conducted specifically on Dunnia sinensis extracts, dunnisinoside, or dunnisinin to evaluate anti-inflammatory activity. The entirety of phytochemical science on this plant consists of a single isolation study (Wei et al., 2000), which identified the compounds but did not report pharmacological testing. The anti-inflammatory attribution is therefore based solely on:

The folk medicinal use recorded in the primary literature.
The structural membership of dunnisinoside within the plumieride-type iridoid glucoside class, for which anti-inflammatory activity has been demonstrated in other species.

Evidence strength: Extremely preliminary. There are no published in vitro, in vivo (animal), or human data on the isolated compounds or crude extracts of this specific plant regarding anti-inflammatory or any other pharmacological endpoint. Any pharmacological inference rests entirely on chemical class analogy.

6.2 Antimicrobial Activity

No studies on antimicrobial activity of Dunnia sinensis extracts or its specific compounds have been identified in the peer-reviewed literature. Antimicrobial activity is documented for structural analogues of dunnisinoside (plumieride-type iridoids) from other plant genera, but this cannot be attributed to D. sinensis compounds without direct experimental evidence.

6.3 Other Health Areas

No published data associate Dunnia sinensis with any specific body system beyond the general anti-inflammatory folk application. No research into cardiovascular, neuroprotective, hepatoprotective, antitumor, or other health applications of this plant or its unique compounds has been published in accessible peer-reviewed literature.

7. Genomic and Phylogenetic Research

While not directly related to medicinal application, genomic studies of D. sinensis represent the majority of published scientific output on this species.

Dunnia sinensis, a monotypic genus of the Rubiaceae, is an endangered species endemic to China. Its complete chloroplast genome was determined to be 154,909 bp in length and the GC content was 37.80%. The sequence includes a large single-copy region of 84,894 bp, a small single-copy region of 16,973 bp, and the inverted region of 26,521 bp in length. It contains 130 genes, including 84 protein-coding genes, 37 tRNA genes, and 8 rRNA genes.

Phylogenetic studies place Dunnia within the Hedyotideae tribe, closely related to genera like Hymenopogon, based on shared traits such as raphide crystals in tissues and capsule fruit morphology, though it has been historically misclassified in other tribes like Cinchoneae.

Despite extensive efforts, parts of the phylogeny of the angiosperm family Rubiaceae have not been fully resolved. Phylogenetic analyses of 149 taxa and five plastid gene regions show that three enigmatic genera — including Dunnia — are sisters to considerably species-rich clades.

8. Forms of the Plant and Preparations

Dunnia sinensis does not appear in any commercial dietary supplement products, standardized herbal preparations, pharmacopeial monographs, or regulatory frameworks for herbal medicines (including those of the WHO, EMA, ESCOP, or the German Commission E). Its extreme rarity — with only five known wild populations and protected status as a national key wild plant in China — makes large-scale harvest or commercial preparation essentially impossible.

The only documented preparation in the scientific literature is the ethanolic extraction of powdered, dried leaves used in the Wei et al. (2000) isolation study. The ethanol percolate of the powdered dry leaves was fractionated with petroleum, CHCl₃ and n-BuOH, and the n-BuOH-soluble fraction was subjected to chromatography on a silica gel column, followed by recrystallization. This is a laboratory procedure for compound isolation, not a preparation intended for human consumption.

No commercially standardized extract, tincture, capsule, tablet, powder, or other supplement form of Dunnia sinensis has been identified in the scientific or regulatory literature. No dosage forms applicable to human use are described anywhere in the peer-reviewed record.

9. Dosage: Absence of Applicable Data

No clinical studies, human trials, or formal preclinical dose-finding studies have been conducted for Dunnia sinensis or its isolated compounds, dunnisinoside or dunnisinin. Accordingly, no dosage information — whether for the whole plant, any extract, or purified compounds — has been established or reported in any scientific, regulatory, or pharmacopeial source. No NOAEL, LOAEL, or therapeutic dose range exists in the literature for this plant or its unique phytochemicals.

10. Safety Considerations

No toxicological studies — including acute toxicity, subacute toxicity, genotoxicity, reproductive toxicity, or allergenicity assessments — have been published for Dunnia sinensis extracts, dunnisinoside, or dunnisinin. No adverse event reports, drug interaction data, or contraindication profiles exist in the peer-reviewed or regulatory literature for this plant.

The following observations can be made based on verifiable facts:

Endangered and protected status: As of 2020, D. sinensis remains an endangered species listed as a national key protected wild plant in China. Harvesting or trade of wild specimens is therefore subject to Chinese national law protecting wild plant species.
No pharmacopeial recognition: The plant and its compounds are not included in any national or international pharmacopeia, and thus carry no official safety evaluation or regulatory approval as a dietary supplement or medicinal product in any jurisdiction.
No clinical safety data: Without any human or systematic preclinical studies, the safety profile of any preparation derived from D. sinensis is entirely unknown.
Iridoid class general considerations: The water solubility and glycosidic linkages of iridoid glycosides facilitate absorption and targeted delivery. The broader pharmacokinetics and safety data for this compound class are derived from other iridoids and cannot be directly extrapolated to dunnisinoside or dunnisinin without species-specific studies.

11. Summary and State of Research

Dunnia sinensis is a botanically distinctive, critically endangered, and scientifically understudied plant. Its only documented pharmacological relevance is a single-sentence characterization of folk anti-inflammatory use, corroborated by a single phytochemical isolation study (Wei et al., 2000) that identified two novel iridoid compounds — dunnisinoside and dunnisinin — from its leaves. No pharmacological, toxicological, clinical, or dosage studies have been published on this plant or its unique constituents. The plant is not commercially available as a supplement or herbal medicine, and its protected endangered status makes it unavailable for harvest.

The chemical class to which its principal constituent (dunnisinoside, a plumieride-type iridoid glucoside) belongs is well-studied in other genera, with established anti-inflammatory, antioxidant, antimicrobial, and other activities. However, these class-level findings cannot be reliably applied to D. sinensis-specific compounds without independent experimental confirmation. The current state of knowledge represents a preliminary phytochemical identification stage with no downstream pharmacological development reported in the scientific literature.

References

Health Conditions

Health conditions that Dunnia sinensis may help support.

No conditions available.

Body Systems

Body systems that Dunnia sinensis may help support.

No body systems available.